Can You Take Duloxetine with Sertraline?
A plain-English look at the moderate interaction between Duloxetine (APO-Duloxetine) and Sertraline (Zoloft) — what it means, why it happens, and what to talk to your doctor or pharmacist about.
Combining Duloxetine (APO-Duloxetine) with Sertraline (Zoloft) is a moderate interaction requiring caution and monitoring. Risk of serotonin syndrome, especially with tramadol and tapentadol combined with SSRIs/SNRIs. Additive CNS depression with sedating antidepressants.
Not sure about your specific combination? Check it in the Drug Interaction Checker →
Key Takeaways
- Interaction severity: Moderate
- Risk: Serotonin syndrome (agitation, hyperthermia, rigidity), excessive sedation.
- Mechanism: Risk of serotonin syndrome, especially with tramadol and tapentadol combined with SSRIs/SNRIs. Additive CNS depression with sedating antidepressants.
- Duloxetine: S4 in Australia, low risk
- Sertraline: S4 in Australia, low risk
- Claims action: Monitor and document. Request clinical justification if combination is ongoing.
Duloxetine vs Sertraline at a Glance
| Property | Duloxetine | Sertraline |
|---|---|---|
| Brand names | APO-Duloxetine, Duloxetine Sandoz 60, Tixol 60 | Zoloft, Eleva 50, Setrona |
| Drug class | opioid | antidepressant |
| Risk level | low | low |
| TGA Schedule (AU) | S4 | S4 |
Why Is This Combination Dangerous?
Risk of serotonin syndrome, especially with tramadol and tapentadol combined with SSRIs/SNRIs. Additive CNS depression with sedating antidepressants.
Regulatory Guidance by Jurisdiction
Australia TGA / SIRA / WorkSafe
The TGA and Australian Medicines Handbook classify this as a moderate drug interaction requiring monitoring and clinical review.
United Kingdom NICE / MHRA / FPM
NICE guidelines advise against combining multiple serotonergic medications due to the risk of serotonin syndrome. For personal injury claims, antidepressant prescribing should be reviewed for injury relatedness and appropriateness.
United States FDA / CDC / State WC
The FDA has issued Drug Safety Communications about the risk of serotonin syndrome with concurrent use of serotonergic medications. Workers compensation nurse case managers should flag this combination for prescriber review.
What Claims Professionals Should Do
- Document the combination in the claim file with a note on interaction risk
- Request clinical justification from the prescriber at the next review
- Monitor for adverse effects including excessive sedation, falls, and cognitive impairment
- Assess injury relatedness of both medications to the compensable condition
- Review at next claim assessment and consider whether the combination is still clinically appropriate
Clinical reference
A clinical summary of Duloxetine and Sertraline drawn from regulator advisories, national guidelines, and authoritative drug references. Read this if you want the deeper clinical picture before talking to your prescriber or pharmacist.
Severity assessment
Major. The primary risk is the development of serotonin syndrome, a potentially life-threatening condition.
Mechanism (plain English)
Both duloxetine and sertraline work by increasing the levels of serotonin, a chemical messenger, in the brain. Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI), and sertraline is a selective serotonin reuptake inhibitor (SSRI). When these two medications are taken together, the combined effect can lead to an excessive accumulation of serotonin in the central nervous system, resulting in a condition known as serotonin syndrome.
Evidence level
Regulator-flagged. The U.S. Food and Drug Administration (FDA) label for duloxetine explicitly warns about the increased risk of serotonin syndrome when co-administered with other serotonergic agents.
Top regulator advisories (cite verbatim or close paraphrase)
- TGA (Australia): No pair-specific public advisory found for duloxetine and sertraline interaction. However, the Australian Register of Therapeutic Goods (ARTG) product information for duloxetine (e.g., APO-DULOXETINE) generally advises caution with concomitant use of other serotonergic drugs due to the risk of serotonin syndrome.
- MHRA / NICE (UK): No specific guidance found for this exact drug pair. However, general guidance on Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin and Noradrenaline Reuptake Inhibitors (SNRIs) from the MHRA highlights the potential for central nervous system toxicity when used with other serotonergic agents.
- FDA / CDC (US): The FDA-approved label for Cymbalta (duloxetine) states: "Serotonin Syndrome: Increased risk when co-administered with other serotonergic agents (e.g., SSRIs, SNRIs, triptans), but also when taken alone. If it occurs, discontinue CYMBALTA (5.4)." [1]
- EMA (Europe): No specific EMA advisory found for this drug pair.
Clinical risk factors that elevate the danger
- Higher Doses: Increased dosages of either duloxetine or sertraline can elevate the risk of serotonin syndrome.
- Individual Sensitivity: Genetic variations in drug metabolism or individual patient sensitivity to serotonin can increase susceptibility.
- Concomitant Use of Other Serotonergic Drugs: Concurrent use of other medications that increase serotonin levels (e.g., triptans, tricyclic antidepressants, MAOIs, St. John's Wort, tramadol, fentanyl) significantly raises the risk.
- Rapid Dose Escalation: Quickly increasing the dose of either medication can precipitate serotonin syndrome.
What a patient should be told
- Risk of Serotonin Syndrome: Combining duloxetine and sertraline can lead to a serious condition called serotonin syndrome, which is caused by too much serotonin in your brain. Symptoms can include confusion, agitation, sweating, shivering, muscle stiffness, or rapid heart rate.
- Do Not Stop Suddenly: Do not stop taking either medication or change your dose without first talking to your doctor or pharmacist. Suddenly stopping can cause withdrawal symptoms or worsen your condition.
- Warning Signs: Be aware of the symptoms of serotonin syndrome. If you experience any of these, especially if they are severe or come on quickly, seek medical attention immediately.
- Discuss Alternatives: Always discuss all your medications, including over-the-counter drugs, supplements, and herbal remedies, with your doctor or pharmacist. They can help determine the safest treatment plan for you.
- Urgent Care Triggers: If you develop a high fever, seizures, or become unconscious, seek urgent medical care immediately.
Top 3 sources (with full citation)
- U.S. Food and Drug Administration. Cymbalta (duloxetine) Prescribing Information. Revised 04/2020. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021427s052lbl.pdf
- Drugs.com. Duloxetine and Sertraline Drug Interactions. Available at: https://www.drugs.com/drug-interactions/duloxetine-with-sertraline-949-0-2057-0.html
- Australian Register of Therapeutic Goods (ARTG). APO-DULOXETINE duloxetine (as hydrochloride) 60 mg enteric capsule blister. Available at: https://www.tga.gov.au/resources/artg/427037
Notes for the reviewing pharmacist
This interaction is classified as Major due to the significant risk of serotonin syndrome. While co-administration is generally discouraged, it may occur in clinical practice under careful monitoring. Pharmacists should emphasize patient education regarding serotonin syndrome symptoms and the importance of not self-adjusting doses. Awareness of other concomitant serotonergic agents is crucial. The lack of specific advisories from TGA, MHRA, and EMA for this exact pair highlights the need to extrapolate from general warnings about serotonergic agents. Individual patient factors, such as renal or hepatic impairment, and the use of CYP2D6 inhibitors, could further complicate management, though these are not direct interaction mechanisms for serotonin syndrome.
Source metadata JSON
Check this medication against your full medication list
Check all interactions for Duloxetine and Sertraline across your claimant's full medication list.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Related Resources
Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.